Does breast composition influence late adverse effects in breast radiotherapy?

Area of Science:

• Oncology
• Radiotherapy
• Breast Cancer Treatment

Background:

• Large breast size correlates with increased risks of late adverse effects post-breast cancer surgery and radiotherapy.
• Radiotherapy's impact on adipose tissue is a suspected contributor to these effects.
• This study investigated breast composition and other features like fibroglandular tissue, seroma, and scar in relation to late effects.

Purpose of the Study:

• To examine the association between breast composition and late adverse effects following breast cancer radiotherapy.
• To identify other breast features, including seroma and scar, that may be associated with these late effects.

Main Methods:

• Analysis of 18 cases with breast appearance changes and 36 controls at 2-year follow-up from the FAST-Pilot and UK FAST trials.
• Assessment of breast composition, fibroglandular tissue distribution, seroma, and scar on planning CT scans.
• Univariate and logistic regression analyses, including conditional logistic regression for matched analysis, were used to test associations.

Main Results:

• No statistically significant differences in breast features were found between cases and controls in univariate analyses.
• A significant association (p < 0.05) was observed between the amount of seroma and changes in photographic breast appearance.
• Odds ratios for seroma association were 3.44 (1.28-9.21) in unmatched and 2.57 (1.05-6.25) in matched analyses.

Conclusions:

• Seroma formation is significantly associated with late adverse effects after radiotherapy for breast cancer.
• Breast composition was not found to be significantly associated with late adverse effects in this cohort.
• The role of large breast size as a risk factor for late effects after surgery and radiotherapy remains undetermined.